BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

680 related articles for article (PubMed ID: 23911607)

  • 1. Mechanistic analysis of allosteric and non-allosteric effects arising from nanobody binding to two epitopes of the dihydrofolate reductase of Escherichia coli.
    Oyen D; Wechselberger R; Srinivasan V; Steyaert J; Barlow JN
    Biochim Biophys Acta; 2013 Oct; 1834(10):2147-57. PubMed ID: 23911607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constraining enzyme conformational change by an antibody leads to hyperbolic inhibition.
    Oyen D; Srinivasan V; Steyaert J; Barlow JN
    J Mol Biol; 2011 Mar; 407(1):138-48. PubMed ID: 21238460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solvent environments significantly affect the enzymatic function of Escherichia coli dihydrofolate reductase: comparison of wild-type protein and active-site mutant D27E.
    Ohmae E; Miyashita Y; Tate S; Gekko K; Kitazawa S; Kitahara R; Kuwajima K
    Biochim Biophys Acta; 2013 Dec; 1834(12):2782-94. PubMed ID: 24140567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric communication in dihydrofolate reductase: signaling network and pathways for closed to occluded transition and back.
    Chen J; Dima RI; Thirumalai D
    J Mol Biol; 2007 Nov; 374(1):250-66. PubMed ID: 17916364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of ligand exchange kinetics via active-site trapping with an antibody fragment.
    Oyen D; Steyaert J; Barlow JN
    Biochemistry; 2014 Apr; 53(12):1879-81. PubMed ID: 24617671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric inhibition of VIM metallo-β-lactamases by a camelid nanobody.
    Sohier JS; Laurent C; Chevigné A; Pardon E; Srinivasan V; Wernery U; Lassaux P; Steyaert J; Galleni M
    Biochem J; 2013 Mar; 450(3):477-86. PubMed ID: 23289540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational selection and induced changes along the catalytic cycle of Escherichia coli dihydrofolate reductase.
    Weikl TR; Boehr DD
    Proteins; 2012 Oct; 80(10):2369-83. PubMed ID: 22641560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational changes in the active site loops of dihydrofolate reductase during the catalytic cycle.
    Venkitakrishnan RP; Zaborowski E; McElheny D; Benkovic SJ; Dyson HJ; Wright PE
    Biochemistry; 2004 Dec; 43(51):16046-55. PubMed ID: 15609999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structurally distributed surface sites tune allosteric regulation.
    McCormick JW; Russo MA; Thompson S; Blevins A; Reynolds KA
    Elife; 2021 Jun; 10():. PubMed ID: 34132193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-idiotypic antibodies elicited by pterin recognize active site epitopes in dihydrofolate reductases and dihydropteridine reductase.
    Ratnam S; Ratnam M; Cotton RG; Jennings IG; Freisheim JH
    Arch Biochem Biophys; 1989 Dec; 275(2):344-53. PubMed ID: 2480746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis of nanobody-mediated blocking of BtuF, the cognate substrate-binding protein of the Escherichia coli vitamin B12 transporter BtuCD.
    Mireku SA; Sauer MM; Glockshuber R; Locher KP
    Sci Rep; 2017 Oct; 7(1):14296. PubMed ID: 29084999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strength of an interloop hydrogen bond determines the kinetic pathway in catalysis by Escherichia coli dihydrofolate reductase.
    Miller GP; Benkovic SJ
    Biochemistry; 1998 May; 37(18):6336-42. PubMed ID: 9572848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased substrate affinity in the Escherichia coli L28R dihydrofolate reductase mutant causes trimethoprim resistance.
    Abdizadeh H; Tamer YT; Acar O; Toprak E; Atilgan AR; Atilgan C
    Phys Chem Chem Phys; 2017 May; 19(18):11416-11428. PubMed ID: 28422217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further studies on the role of water in R67 dihydrofolate reductase.
    Timson MJ; Duff MR; Dickey G; Saxton AM; Reyes-De-Corcuera JI; Howell EE
    Biochemistry; 2013 Mar; 52(12):2118-27. PubMed ID: 23458706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homology building as a means to define antigenic epitopes on dihydrofolate reductase (DHFR) from Plasmodium falciparum.
    Alifrangis M; Christensen IT; Jørgensen FS; Rønn AM; Weng JE; Chen M; Bygbjerg IC; Sirawaraporn W; Palarasah Y; Koch C
    Malar J; 2004 Jun; 3():16. PubMed ID: 15193156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of water in the catalytic cycle of E. coli dihydrofolate reductase.
    Shrimpton P; Allemann RK
    Protein Sci; 2002 Jun; 11(6):1442-51. PubMed ID: 12021443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining the Structural Basis for Allosteric Product Release from E. coli Dihydrofolate Reductase Using NMR Relaxation Dispersion.
    Oyen D; Fenwick RB; Aoto PC; Stanfield RL; Wilson IA; Dyson HJ; Wright PE
    J Am Chem Soc; 2017 Aug; 139(32):11233-11240. PubMed ID: 28737940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cofactor-Mediated Conformational Dynamics Promote Product Release From Escherichia coli Dihydrofolate Reductase via an Allosteric Pathway.
    Oyen D; Fenwick RB; Stanfield RL; Dyson HJ; Wright PE
    J Am Chem Soc; 2015 Jul; 137(29):9459-68. PubMed ID: 26147643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tail wagging the dog: insights into catalysis in R67 dihydrofolate reductase.
    Kamath G; Howell EE; Agarwal PK
    Biochemistry; 2010 Oct; 49(42):9078-88. PubMed ID: 20795731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A glutamine 67--> histidine mutation in homotetrameric R67 dihydrofolate reductase results in four mutations per single active site pore and causes substantial substrate and cofactor inhibition.
    Park H; Bradrick TD; Howell EE
    Protein Eng; 1997 Dec; 10(12):1415-24. PubMed ID: 9543003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.